Therapeutic Area Expertise

Where Science Meets Strategy, Across Every Therapeutic Frontier

We bring deep therapeutic fluency to every engagement, combining scientific rigour, patient insight, and strategic clarity across disease areas and modalities.

Whether you're advancing a rare asset, launching in oncology, or navigating stigma in mental health, we tailor strategy and content to meet the expectations of regulators, payers, clinicians, investors, and always, patients.

Areas of Focus

Rare & Autoimmune Diseases

Experience with orphan drug submissions, value messaging, and patient-informed strategy, including thyroid eye disease (TED) and other ultra-rare conditions.

Neurology & Neuroscience

Support across neurodegeneration, epilepsy, movement disorders, and cognitive decline, spanning preclinical to commercial.

Mental Health & Psychedelics

Strategic communications for psychedelic-assisted therapies and emerging mental health platforms, balancing innovation, empathy, and compliance.

Oncology & Immunotherapy

Mechanism-of-action storytelling, complex trial data interpretation, and multi-stakeholder value narratives.

Gene & Cell Therapies

Global launch support for curative modalities, bridging regulatory complexity with clinical and access strategy.

Infectious Diseases & Vaccines

Agile development and delivery of content for pandemic preparedness, public health campaigns, and novel vaccines.

Women’s Health

Messaging across fertility, contraception, menopause, and hormone-related care, designed with cultural awareness and inclusion.

Respiratory, Metabolic & Dermatology

Lifecycle content and market adaptation tools for both chronic and acute conditions.

Why It Matters

Each condition brings its own stakeholders, sensitivities, and scientific nuance. We meet those challenges with therapeutic understanding, cross-functional collaboration, and tailored delivery approaches prioritising clarity, speed, and strategic impact.